AFYREN Announces the Signing of Two Strategic Contracts for AFYREN NEOXY in the Nutrition and Health Markets
21 Dezember 2021 - 7:30AM
Business Wire
- Sales accounting for 60% of the AFYREN NEOXY factory’s
projected acid production at full capacity are secured1
- Food and feed markets are growing more than 6%
annually2
Regulatory News:
AFYREN (Paris:ALAFY), a greentech company that offers
manufacturers natural, low-carbon products created with technology
based on natural micro-organisms, has signed two strategic
contracts for the long-term supply of biobased ingredients by
AFYREN NEOXY to two major players in the nutrition (human and
animal) and health markets.
The two contracts were established with major companies that are
leaders in their sectors:
- the first is for the manufacture of high quality food
ingredients, particularly for the confectionery, meat, chocolate
and dairy markets
- the second is for the manufacture of nutritional and health
products for animals.
The markets addressed by these partners have significant growth
potential amid increasing consumer demand for natural and bio-based
products. AFYREN is responding to these trends by ensuring a local
supply chain for the raw materials used by its AFYREN NEOXY plant
and through its innovative proprietary technology platform.
Data Bridge Market Research analysis shows that the animal
nutrition market is expected to grow at a compound annual growth
rate of 6.5% for the 2021 to 2028 period. The human nutrition
market is growing at a similar rate, according to a report from
Wellness Creative Co.
Taking into account these deals, 60% (by volume) of the organic
acid output to be produced by the AFYREN NEOXY plant is already
pre-sold.
Nicolas SORDET, AFYREN's CEO, said: "In the wake of the
recently announced partnership with ENNOLYS, these two new
agreements underscore the attractiveness of our products and our
unique positioning — based on a circular economy and a
zero-industrial-waste approach. The markets we will be addressing
are growing steadily and are experiencing significant demand for
sustainable and biobased ingredients, driven by consumers who are
seeking healthier and more responsible lifestyles. By ensuring the
supply of these two leading players in animal nutrition and human
food, we are taking additional steps to secure future revenue for
AFYREN NEOXY while positioning ourselves as a leading supplier of
biobased organic acids at the European level. This allows us to
continue to guarantee a successful start for this first plant and
approach its ramp-up with confidence."
About AFYREN
Founded in 2012 to meet the growing need of industries to reduce
the use of petroleum derivatives in their production chain, AFYREN
produces biomolecules derived from the reuse of non-food biomass.
These ingredients are widely used in human and animal nutrition,
flavors and fragrances, cosmetics, and fine chemicals. This
production of renewable carbon, which is firmly grounded in the
circular economy, uses fermentation technologies that are the
result of 10 years of research and are patented worldwide. AFYREN
is a winner of the 2030 Global Innovation Contest in the "Plant
proteins and plant chemistry" category and was selected in the
French Tech 120 in 2020 and 2021. In 2018, AFYREN committed to its
industrial project by creating the AFYREN NEOXY joint venture with
Bpifrance’s SPI fund. The AFYREN NEOXY plant under construction in
the Grand Est region will produce AFYREN organic acids in 2022.
AFYREN and AFYREN NEOXY employ more than 70 people at their sites
in Lyon, Clermont-Ferrand and Carling Saint-Avold. In 2021, AFYREN
listed on Euronext Growth® exchange in Paris, raising a total
amount of 70.4 million euros with the objective of accelerating its
industrial development (Afyren's ISIN: FR0014005AC9, ticker:
ALAFY).
For more information: afyren.com
_____________________ 1 Excluding fertilizer production already
pre-sold at 100% 2
https://www.wellnesscreatives.com/nutrition-industry-statistics/
&
https://www.databridgemarketresearch.com/reports/global-animal-nutrition-market
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211220005799/en/
AFYREN Chief Financial Officer Maxime Cordonnier
investisseurs@afyren.com
Investor Relations NewCap Théo Martin 01 44 71 94
94 afyren@newcap.eu
Media Relations NewCap Nicolas Merigeau 01 44 71
94 98 afyren@newcap.eu
Afyren (EU:ALAFY)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Afyren (EU:ALAFY)
Historical Stock Chart
Von Apr 2023 bis Apr 2024